Authors:
Bixo, M
Allard, P
Backstrom, T
Mjorndal, T
Nyberg, S
Spigset, O
Sundstrom-Poromaa, I
Citation: M. Bixo et al., Binding of [H-3]paroxetine to serotonin uptake sites and of [H-3]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment, PSYCHONEURO, 26(6), 2001, pp. 551-564
Authors:
Wihlback, AC
Sundstrom-Poromaa, I
Nyberg, S
Backstrom, T
Citation: Ac. Wihlback et al., Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy, NEUROENDOCR, 73(6), 2001, pp. 397-407
Authors:
Talvik, M
Nordstrom, AL
Nyberg, S
Olsson, H
Halldin, C
Farde, L
Citation: M. Talvik et al., No support for regional selectivity in clozapine-treated patients: A PET study with [C-11]raclopride and [C-11]FLB 457, AM J PSYCHI, 158(6), 2001, pp. 926-930
Citation: S. Nyberg et L. Farde, Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies, PSYCHOPHAR, 148(1), 2000, pp. 22-23
Authors:
Bjorn, I
Bixo, M
Nojd, KS
Nyberg, S
Backstrom, T
Citation: I. Bjorn et al., Negative mood changes during hormone replacement therapy: A comparison between two progestogens, AM J OBST G, 183(6), 2000, pp. 1419-1426
Citation: Sj. Offord et al., The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action, J CLIN PHAR, 39, 1999, pp. 17S-24S
Authors:
Nyberg, S
Eriksson, B
Oxenstierna, G
Halldin, C
Farde, L
Citation: S. Nyberg et al., Suggested minimal effective dose of risperidone based on PET-measured D-2 and 5-HT2A receptor occupancy in schizophrenic patients, AM J PSYCHI, 156(6), 1999, pp. 869-875
Authors:
Sundstrom, I
Nyberg, S
Bixo, M
Hammarback, S
Backstrom, T
Citation: I. Sundstrom et al., Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen, ACT OBST SC, 78(10), 1999, pp. 891-899